血凝酶序贯低分子肝素用于骨科手术围术期有效性及安全性的系统评价

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (1158 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To systematically the effect of hemocoagulase sequential low molecular weight heparin treatment on hemorrhage and postoperative coagulation function of patients during perioperative period of orthopedic surgery. Methods Randomized controlled trials (RCTs) on the using of hemocoagulase during orthopedic surgery and low-molecular-weight heparin before surgery were searched from the building database to November 11, 2017 in CNKI, Wanfang Data, PubMed, and the references of all RCTs were further traced. After RCTs screening, data extraction, and quality evaluation carried out by two researchers according to the standards, RevMan 5.3.0 was used for Meta analysis. Results Six hundred and ninety-nine patients of 6 RCTs were included in 22 preliminary screening articles. The Meta analysis showed that, compared with control group, the intraoperative blood loss (SMD = -3.02, 95%CI [-4.44, -1.59], P ＜ 0.0001) and 24 h postoperative blood loss (SMD = -1.44, 95%CI [-2.50, -0.38], P = 0.008) of study group decreased significantly. There was no statistically significant difference in 24 h prothrombin time, partial thromboplastin time, fibrinogen (P > 0.05). Conclusion The therapeutic schedule of hemocoagulase sequential low molecular weight heparin during perioperative period of orthopedic surgery can reduce the peroperative bleeding and drainage 2 h after the operation, without increasing the incidence of adverse events, it has better security.

Key words： Hemocoagulase Low-molecular-weight heparin Coagulation Systematic evaluation Meta analysis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Yue1 TIAN Liu2 CHEN Ying1 ZHOU Benhong1

Cite this article:

WU Yue1 TIAN Liu2 CHEN Ying1 ZHOU Benhong1. Systematic evaluation of the efficacy and safety of hemagglutinase sequential low molecular weight heparin for perioperative hemostasis in orthopedic surgery[J]. 中国医药导报, 2019, 16(24): 86-90.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2019/V16/I24/86

[1] 王晓芳，李笠，张运剑.1996-2015年北京积水潭医院住院肺血栓栓塞症患者临床流行病学特征及诊治变迁情况[J].中国全科医学，2017，20（24）：3004-3007，3014.
[2] Cafri G，Paxton EW，Chen Y，et al. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty [J]. J Arthroplasty，2017，32（11）：3524-3528.
[3] Arnold PM，Harrop JS，Merli G，et al. Efficacy，Safety，and Timing of Anticoagulant Thromboprophylaxis for the Prevention of Venous Thromboembolism in Patients With Acute Spinal Cord Injury：A Systematic Review [J]. Global Spine J，2017，7（3 Suppl）：138S-150S.
[4] 中华医学会血栓栓塞性疾病防治委员会.构建医院内静脉血栓栓塞症防治和管理体系[J].中华医院管理杂志，2013，29（1）：28-31.
[5] Nam JH，Kim DH，Yoo JH，et al. Does preoperative mechanical prophylaxis have additional effectiveness in preventing postoperative venous thromboembolism in elderly patients with hip fracture?-Retrospective case-control study [J]. PLoS One，2017，12（11）：e0187337.
[6] Chul SW ，Min LS，Tak SK. Recent Updates of the Diagnosis and Prevention of Venous Thromboembolism in Patients with a Hip Fracture [J]. Hip Pelvis，2017，29（3）：159-167.
[7] Amin EE，Joore MA，Ten CH，et al. Clinical and economic impact of compression in the acute phase of deep vein thrombosis [J]. J Throm Haemost，2018，16（8）：1555-1563.
[8] Wu EQ，Xie J，Wu C，et al. Treatment，monitoring，and economic outcomes of venous thromboembolism among hospitalized patients in China [J]. Pharmacoeconomics，2014， 32（3）：305-313.
[9] 高远，龙安华，孟钰童，等.预防骨科围术期静脉血栓栓塞症的研究进展[J].解放军医学院学报，2018，39（5）：447-450.
[10] Streiff MB，Haut ER. The CMS ruling on venous thromboembolism after total knee or hip arthroplasty：weighing risks and benefits [J]. JAMA，2009，301（10）：1063-1065.
[11] Thirugnanam S，Pinto R，Cook DJ，et al. Economic analyses of venous thromboembolism prevention strategies in hospitalized patients：a systematic review [J]. Critical Care，2012，16（2）：R43.
[12] 中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志，2016，36（2）：65-71.
[13] Xia ZN，Zhou Q，Zhu W，et al. Low molecular weight heparin for the prevention of deep venous thrombosis after total knee arthroplasty：A systematic review and meta-analysis [J]. Int J Surg，2018，54（Pt A）：265-275.
[14] 岳辰，周宗科，裴福兴，等.中国髋、膝关节置换术围术期抗纤溶药序贯抗凝血药应用方案的专家共识[J].中华骨与关节外科杂志，2015，8（4）：281-285.
[15] 邓波，王静成，熊传芝，等.巴曲亭应用于全髋关节置换术对手术出血的影响[J].临床骨科杂志，2016，19（5）：567-569.
[16] 丁冠男，李树人，潘振祥，等.巴曲亭对低分子肝素抗凝全髋置换术患者出血量及凝血功能影响的研究[J].中华流行病学杂志，2014，35（6）：737-740.
[17] 周绍春，陶国才.老年全膝关节置换术72例低分子肝素配伍巴曲亭抗凝效果观察[J].陕西医学杂志，2013， 42（1）：75-77.
[18] 丁冠男，李彦平，李树人.蛇毒巴曲酶对肝素抗凝者术中凝血功能影响的研究[J].人民军医，2009，52（6）：364.
[19] 陆伟斌，唐亚贤，刘宝清，等.血凝酶对髋关节置换术低分子肝素抗凝患者出血量及凝血功能的影响[J].现代生物医学进展，2016，16（29）：5713-5715.
[20] 王丹，李艳辉，麻海春.注射用血凝酶术前给药对低分子肝素抗凝患者髋关节置换术围手术期出血量及凝血功能的影响[J].国际麻醉学与复苏杂志，2013，34（6）：513-515，519.